Prospective cohort study. We included all adults with solid or hematologic cancer
receiving active chemotherapy treatment during the winter of 2010e2011 in a cancer center.
We compared baseline characteristics and outcomes between patients with and without
chemotherapy delays, cancellations, or dose-reductions (“chemotherapy delay”).